Management of drug and food interactions with azole antifungal agents in transplant recipients.
about
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveAntifungal Prophylaxis in Immunocompromised PatientsDrug-drug interaction between isavuconazole and tacrolimus: a case report indicating the need for tacrolimus drug-level monitoring.Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain.Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.Topical tacrolimus with custom trays in the treatment of severe oral chronic graft-versus-host disease refractory to a potent topical steroid therapy: a case reportDrug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathyEfficacy of Propolis on the Denture Stomatitis Treatment in Older Adults: A Multicentric Randomized Trial.Current concepts in antifungal pharmacology.Triazole antifungal agents in invasive fungal infections: a comparative review.Safety of posaconazole.Treatment principles for the management of mold infections.Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014.Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.Antifungal stewardship considerations for adults and pediatrics.Alternaria alternata invasive fungal infection in a patient with Fanconi's anemia after an unrelated bone marrow transplant.Rifampin-sirolimus-voriconazole interaction in a hematopoietic cell transplant recipient.Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.Use of different parameters and equations for calculation of IC₅₀ values in efflux assays: potential sources of variability in IC₅₀ determination.Cryptococcosis in solid organ transplantation.Phomopsis bougainvilleicola prepatellar bursitis in a renal transplant recipient.Potent Antifungal Synergy of Phthalazinone and Isoquinolones with Azoles Against Candida albicans.Sirolimus and mirabegron interaction in a hematopoietic cell transplant patient.Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation.Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.Clinical impact and management of fluconazole discontinuation on sirolimus levels in bone marrow transplant patients.
P2860
Q27009221-300DC3DB-583B-4250-9D86-F05340691D03Q28074168-0902E84D-0AC8-456B-A986-D1B677DDA8BDQ33769966-C7B710FD-B13B-4214-A94E-DBD025FE6E0AQ34281346-E31DB9BB-7FD3-4483-AC26-E96D4B0A2E0AQ35754431-AD68F43D-1E93-47F0-B4E1-B2545B75E14EQ35936943-F91542E2-9C64-41BF-94FE-58EDF9080C9EQ36681070-B8A67DFA-7D80-4135-B285-BA744034290CQ36933464-E207F044-96BE-4670-9E44-B563DDD05A97Q37303616-8B504AF1-43A5-4601-A228-4386875AAD2DQ37726955-7F08A1F4-3E4F-4C3F-B40A-3F56E138641EQ37908856-8B02CF52-37E8-4F82-9B02-3D4EFD40A45EQ37964703-10830B80-1BC0-4473-8210-7206F2BB60E7Q38077591-72D2BC0E-6ECF-44A4-9681-401A97D2FE38Q38265845-BA0935C9-69A7-46B6-AF24-55D1BC5EE588Q38284468-8F910AE0-30FF-42F9-887B-DE132E04F085Q38738090-9D8BFD4F-1BF0-4C43-8B6E-B238858EFB87Q38944746-1AFD7CFD-8019-48DC-A40E-327DFEA601CAQ40257946-6B8AAA79-512E-47EA-A6C0-1527D610AD5CQ40834681-E74950D9-48C5-4D54-AE7C-1D4D3B58D0F3Q41572274-DE47F8E6-8FDA-44B4-BC75-8A4066C35C3BQ41867627-8ADCC916-78FB-4E4D-8903-C32534507B8EQ42272288-10533547-BDC5-48DA-B0F4-764095AE9944Q42284523-42C1EC7B-A07D-4583-93D5-CC2C8FF43467Q46806464-AB635A36-B393-4B6B-BE77-C091B9828B9EQ47666188-ECA9D39A-03C4-440F-9238-1EC254AC9EBFQ48238550-F306CD59-E232-4C74-A487-059A76D8D6FBQ50668499-CCF1A82A-0D32-43D1-BCE6-437E9F0A2494Q53510811-36989FE6-D1C1-407D-BA16-C3EB2EDFF2A6
P2860
Management of drug and food interactions with azole antifungal agents in transplant recipients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of drug and food in ...... ents in transplant recipients.
@en
Management of drug and food in ...... ents in transplant recipients.
@nl
type
label
Management of drug and food in ...... ents in transplant recipients.
@en
Management of drug and food in ...... ents in transplant recipients.
@nl
prefLabel
Management of drug and food in ...... ents in transplant recipients.
@en
Management of drug and food in ...... ents in transplant recipients.
@nl
P2860
P356
P1433
P1476
Management of drug and food in ...... ents in transplant recipients.
@en
P2093
Elizabeth Dodds-Ashley
P2860
P304
P356
10.1592/PHCO.30.8.842
P407
P577
2010-08-01T00:00:00Z